Europe Bone Cement Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type [Polymethyl Methacrylate Cement (PMMA), Calcium Phosphate Cement (CPC), Glass Polyalkenoate Cement (GPC), and Others], Application (Arthroplasty, Kyphoplasty, and V

Europe Bone Cement Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type [Polymethyl Methacrylate Cement (PMMA), Calcium Phosphate Cement (CPC), Glass Polyalkenoate Cement (GPC), and Others], Application (Arthroplasty, Kyphoplasty, and Vertebroplasty), and End User [Hospitals, Ambulatory Surgery Centers (ASCs), and Clinics]

The Europe bone cement market is expected to grow from US$ 326.93 million in 2021 to US$ 471.37 million by 2028; it is estimated to grow at a CAGR of 5.4% from 2021 to 2028.

Osteoporosis is characterized by low bone density and deterioration of bone tissue. Osteoporosis increases the risk of fractures. In recent years, there have been growing cases of osteoporosis. For instance, according to an article published by Restore Program in October 2020, each year, osteoporosis causes more than 8.9 million fractures, which corresponds to one every three seconds, with one in three women and one in five men over 50 suffering from an osteoporotic fracture. Similarly, between 2019 and 2034, the population aged 50 and up is expected to grow by 11.4%. Population aged 75 and above increase significantly, with 29.6% in women and 42.6% in men. Moreover, in the 29 countries of Europe (European Union + Switzerland & UK), the number of new fragility fractures was expected to reach 4.3 million in 2019, with 826,708 hip fractures (19%), 636,705 forearm fractures (15%), 662,544 vertebral fractures (16%), and 2,149,591 other fractures (50%). Hip fractures accounted for 43% of fracture-related mortality in women, whereas clinical vertebral fractures accounted for 53%, and other fractures accounted for 3% in 2019. The comparable proportions in men were 34%, 65%, and 1%, respectively. Furthermore, based on fracture counts determined from age- and sex-specific incidence and population size in 5-year age intervals, the annual number of osteoporotic fractures in the 29 countries of Europe (European Union + Switzerland & UK), is predicted to increase by 1.06 million, from 4.28 million in 2019 to 5.34 million in 2034. The percentage rise throughout the 15 years will vary significantly by country, ranging from a moderate 8% growth (Latvia) to a spectacular 58% growth (Ireland). Osteoporosis leads to increased occurrence of fractures and procedures of the joint. Hence, the rising prevalence of osteoporosis is boosting the demand and sales of bone cement, which is contributing to the growth of the Europe bone cement market.

The European economy was severely affected due to the exponential growth of COVID-19 cases in the region. Spain, Italy, Germany, France, and the UK were among the most affected European countries. Several companies experienced severe losses in the last quarter of 2019 and the first and second quarters of 2020. Hence, the impact of COVID-19 on the European market was immediate and drastic. The businesses in the region were hampered due to disruption in the supply chain and an increase in demand. To reduce COVID-19 infection in hospitals and clinics, healthcare practitioners and patients adopted and preferred remote patient treatment. Under these unforeseeable circumstances, the orthopedic practice could not remain unaffected. Many surgical treatments and non-urgent consultations were canceled or postponed. Elective surgery was suspended in many institutions, and the overall volume of orthopedic cases fell dramatically to limit the spread of the virus and reserve and reallocate resources in healthcare personnel (nurses, anesthesiologists), medical equipment (personal protective equipment, ventilators), and beds. The stay at home strategy in Europe resulted in a significant reduction in arthroplasty and arthroscopy surgeries and a decrease in the incidence of trauma cases during the COVID-19 period.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe bone cement market. The Europe bone cement market is expected to grow at a good CAGR during the forecast period.

Europe Bone Cement Market Revenue and Forecast to 2028 (US$ Million)

Europe Bone Cement Market Segmentation

Europe Bone Cement Market – by Type

Polymethyl Methacrylate Cement (PMMA)Calcium Phosphate Cement (CPC)Glass Polyalkenoate Cement (GPC)Others Europe Bone Cement Market – by Application

Arthroplasty Kyphoplasty Vertebroplasty Europe Bone Cement Market – by End User

Hospitals Ambulatory Surgery Centers (ASCs)Clinics Europe Bone Cement Market – by Country

Germany UKFrance Italy Spain Rest of Europe Europe Bone Cement Market - Companies Mentioned

Arthrex, Inc.Cardinal Health Inc.De Puy Synthes (The Orthopedics Company of Johnson & Johnson)DJO Global, Inc.Heraeus Holding Gmb HSmith & Nephew Stryker Corporation Tecres S.p.A.Teknimed Zimmer Biomet

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe bone cement market.      
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe bone cement market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth market trends and outlook coupled with the factors driving the Europe bone cement market, as well as those hindering it  
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution